alexa Waldenstrom Macroglobulinemia | United States| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Relevant Topics

Waldenstrom Macroglobulinemia

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Waldenstrom Macroglobulinemia

    Waldenstrom macroglobulinemia (WM).could be a chronic, indolent, lymphoproliferative disorder. It Is characterised by the presence of a high level of a macroglobulin (immunoglobulin M [IgM]), elevated human body, and also the presence of a lymphoplasmacytic infiltrate within the bone marrow.

  • Waldenstrom Macroglobulinemia

    WM is rare, with associate degree incidence rate of concerning 3 cases per million folks per annum within the U.S. About 1,000 to 1,500 folks area unit diagnosed with WM every year within the U.S. WM is nearly double as common in men because it is in ladies, and it's a lot of common among whites than African Americans. The common age at the time of designation of WM is within the mid-60s.

  • Waldenstrom Macroglobulinemia

    Ought to be supported individual patient and illness characteristics (age, comorbidities,would like for fast illness management, campaign for autologous transplantation, cytopenias, IgM-related complications, hyperviscosity, neuropathy). Autologous vegetative cell transplantation is also thought of in young patients with chemosensitiveillness and in freshly diagnosed patients with very-high-risk options.

  • Waldenstrom Macroglobulinemia

    As WM is Associate in Nursing orphan unwellness, most current therapies square measure hand-me-downs from alternative cancers like leukemia, non-Hodgkin malignant neoplastic disease andmyeloma. Clinical trials to judge new therapies for WM square measure rare, and fewer than five-hitter of cancer patients square measure willing or able to participate in an exceedingly clinical test.


High Impact List of Articles

Conference Proceedings